Lobbying Information
Subject Matters
- Aboriginal Affairs
- Budget
- Defence
- Economic Development
- Employment and Training
- Environment
- Government Procurement
- Health
- Industry
- Internal Trade
- International Relations
- International Trade
- Labour
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Federal Budget & Budget measures act with respect to health care funding and focus on science, technology & innovation
- Regulatory Cooperation Council (RCC) work and focus on medical devices regulations
Policies or Program
- Federal Chemicals Management Plan - with repsect to specific batch chemical reviews that may include a chemical used in our manufacturing operations in Canada
- Federal Innovation Panel (lead by Health Canada) - focused on medical technologies commercialization and adoption in Canada
- Science & Technology strategy with respect to the impact on commcercialization and/or procurement of medical technology in Canada
Policies or Program, Regulation
- Comprehensive Economic and Trade Agreement (CETA), North American Free Trade Agreement (NAFTA) and Trans Pacific Partnership (TPP) trade discussions with a focus on medical devices regulations
Regulation
- Regulations to Amend the Food and Drugs Act - with respect to provisions that would impact approvals and product life-cycle management for medical devices and biopharmacetucials, subsequent entry biologics regulations, orphan/rare disease direction and the disclosure of confidential business information
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Canada Economic Development for Quebec Regions
-
Canadian Institutes of Health Research (CIHR)
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Finance Canada (FIN)
-
Health Canada (HC)
-
House of Commons
-
Indigenous and Northern Affairs Canada
-
Innovation, Science and Economic Development Canada (ISED)
-
Office of the Procurement Ombudsman (OPO)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Public Safety Canada (PS)
-
Senate of Canada
Government institutions added through a monthly communication report
- Global Affairs Canada (GAC)
In-house Corporation Details
Description of activities
Baxter Corporation (Canada) is the Canadian subsidiary of Baxter International, a global health care company. Baxter's BioScience, Medication Delivery and Renal products and services are used to treat Canadians with such medical conditions as cancer, hemophilia, immune deficiencies, infectious diseases, kidney disease and trauma.
Responsible officer name and position during the period of this registration
Stephen Thompson,
President & General Manager
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
7125 Mississauga Rd.
Mississauga, ON L5N 0C2
Canada
Telephone number:
905-369-6576
Parent Company Information
- Baxter International
-
One Baxter Parkway
Deerfield, IL 60015-4625
United States of America
Subsidiary Beneficiary Information
Baxter Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Emmanuel Lazaridis,
Sr Manager, Market Access |
No public offices held
- Stephen Thompson,
President & General Manager |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Sebastien Beauchamp,
Vice-President, Government Affairs, Public Policy & Market Access |
No public offices held
